Explore 3 Stock Ideas & Industry Insights Download Free Report

News

CorMedix to Acquire Heron Therapeutics Assets for $145M Cash Plus Stock

CorMedix Inc. filed a current report on November 9, 2026, disclosing an Asset Purchase Agreement signed November 8, 2026, under which the company agreed to acquire substantially all assets of Heron Therapeutics, Inc. for a combination of cash, stock, royalties, and contingent earn-out payments.

Aakashdeep | 09 November 2026

Tigo Energy Faces Securities Class Action Over EG4 Partnership Revenue Claims

Robbins LLP announced on November 9, 2026, that a securities class action lawsuit has been filed on behalf of investors who purchased or otherwise acquired Tigo Energy (NASDAQ:TYGO) securities between February 24, 2026 and August 4, 2026.

Anjali Anand | 09 November 2026

Director Paul Harvey Buys 500 Matador Shares at $52.72

Director Paul W. Harvey filed a Form 4 with the SEC on November 9, 2026, disclosing a purchase of 500 shares of Matador Resources Co common stock on November 5, 2026, at a price of $52.72 per share.

Manish Choudhary | 09 November 2026

SciSparc Corrects Floor Price to $0.11952 in Note Amendment

SciSparc Ltd. filed a Form 6-K/A on November 9, 2026, amending its November 3, 2026 Form 6-K to correct a typographical error in the Floor Price contained in a Convertible Promissory Note and related Warrant issued to L.I.A. Pure Capital Ltd.

Aakashdeep | 09 November 2026

Davion Healthcare Appoints Vienna Capital for $100M Acquisition Financing

Davion Healthcare Plc filed a Form 6-K on November 9, 2026, disclosing that it entered into a non-exclusive financial advisory agreement with Vienna Capital Partners LLC to support a proposed acquisition financing strategy for 2027.

Anjali Anand | 09 November 2026

Heron Therapeutics to Sell Substantially All Assets to CorMedix for $145M Cash Plus Stock

Heron Therapeutics, Inc. filed a Form 8-K on November 9, 2026, disclosing that on November 8, 2026, it entered into an Asset Purchase Agreement with CorMedix Inc. to sell substantially all of its assets for a combination of cash, stock, royalties, and potential earn-out …

Manish Choudhary | 09 November 2026

Matador CEO Foran Buys 5,000 Shares at $51.36 on Nov 5

Joseph Wm. Foran, Chairman and CEO of Matador Resources Co, filed a Form 4 with the SEC on November 9, 2026, disclosing an open-market purchase of 5,000 shares of common stock on November 5, 2026, at a weighted average price of $51.36 per share.

Vinay Lochav | 09 November 2026

Popular Inc. Books $38M Extra Credit Loss Provision, Q3 2026

Popular, Inc. filed a Current Report on Form 8-K on November 9, 2026, disclosing a $38 million additional provision for credit losses recognized as a subsequent event in its third-quarter 2026 financial statements, stemming from a quick service restaurant borrower that filed for Chapter …

Shwetambri Chauhan | 09 November 2026

ADC Therapeutics Q3 2026: $21M Revenue, $189.2M Cash

ADC Therapeutics SA (NYSE:ADCT) reported its third-quarter 2026 financial results on November 9, 2026, disclosing net product revenues of $21.0 million and cash and cash equivalents of $189.2 million as of September 30, 2026, alongside details of a strategic financial restructuring completed in October …

Aditi Sarkar | 09 November 2026

Roger Wood Named Goodyear Interim CEO as Stewart Departs

The Goodyear Tire & Rubber Company filed an 8-K on November 9, 2026, announcing that board director Roger Wood has been appointed interim chief executive officer, effective immediately, following the departure of Mark Stewart as CEO, president, and board member.

Anjali Anand | 09 November 2026
Support

Hi! How can we help you today?

Loading…